Tacrolimus-based versus cyclosporine-based immunosuppression in hepatitis C virus-infected patients after liver transplantation: a meta-analysis and systematic review.
Most liver transplant recipients receive calcineurin inhibitors (CNIs), especially tacrolimus and cyclosporine, as immunosuppressant agents to prevent rejection. A controversy exists as to whether the outcomes of hepatitis C virus (HCV)-infected liver transplant patients differ based on the CNIs use...
Main Authors: | Zhenmin Liu, Yi Chen, Renchuan Tao, Jing Xv, Jianyuan Meng, Xiangzhi Yong |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4157850?pdf=render |
Similar Items
-
Immunosuppressant Pharmacotherapy: Pharmacokinetic Study of Sirolimus in Cyclosporine or Tacrolimus-Based Immunosuppression in Renal Transplant Patients
by: Fe-lin Lin (Fe-lin Lin Wu), et al.
Published: (2004) -
Biliary diseases in heart transplanted patients: a comparison between cyclosporine a versus tacrolimus-based immunosuppression
by: Stief J, et al.
Published: (2009-05-01) -
Comparison of tacrolimus and cyclosporine for immunosuppression after renal transplantation: An updated systematic review and meta-analysis
by: Anoush Azarfar, et al.
Published: (2018-01-01) -
Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant.
by: Gorden Muduma, et al.
Published: (2016-01-01) -
Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil
by: Augusto Afonso Guerra Júnior, et al.
Published: (2015-01-01)